Full history for every metric is available with a Kvantra account
Sichuan Languang Development Co., Ltd. (600466.SS)
Key financial summary
Financials in CNY| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Total revenue | CNY bn | 25 | 31 | 39 | 43 | 20 | 19 | 17 |
| Operating profit | CNY bn | -1 | - | |||||
| Net profit | CNY bn | 1 | 2 | 3 | 3 | -14 | -26 | -27 |
| EPS reported | CNY | -8.62 | -8.76 | |||||
| Operating cashflow per share | CNY | -0.33 | -0.33 | |||||
| Capex per share | CNY | 0.00 | 0.00 | |||||
| FCF per share | CNY | -0.33 | -0.33 | |||||
| Free cash flow | CNY bn | -1 | -27 | |||||
| Net debt | CNY bn | 44 | 44 | |||||
| Book value equity | CNY bn | -24 | -25 | |||||
| Book value per share | CNY | -7.87 | -8.08 | |||||
| Number of shares | m | 3,034.93 | 3,034.3 | |||||
| DPS (TTM paid) | CNY | 0.10 | 0.00 |
Financial summary
Financials in CNY| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Value | ||||||||
| P/E TTM | x | - | - | |||||
| P/B LTM | x | -0.15 | -0.05 | |||||
| P/S LTM | x | 0.18 | 0.07 | |||||
| P/FCF LTM | x | -3.54 | -0.05 | |||||
| EV/EBITDA LTM | x | -2.20 | -4.97 | |||||
| EV/Sales LTM | x | 2.47 | 2.71 | |||||
| Earnings Yield LTM | % | -736.73% | -2154.9% | |||||
| FCF Yield | % | -28.24% | -2189.3% | |||||
| Quality | ||||||||
| ROE | % | 109.59% | 232.40% | |||||
| ROIC | % | -5.06% | -5.06% | |||||
| Operating margin | % | -7.68% | -7.68% | |||||
| Gross margin | % | 4.87% | 4.87% | |||||
| FCF/Sales | % | -5.19% | -5.19% | |||||
| Growth and momentum | ||||||||
| EPS Growth YoY | % | - | - | |||||
| Sales Growth YoY | % | -4.04% | -17.79% | |||||
| Net Income Growth YoY | % | - | - | |||||
| FCF Growth | % | - | - | |||||
| Operating Profit Growth | % | - | - | |||||
| Dividend and capital structure | ||||||||
| Dividend Yield | % | 8.83% | 0.00% | |||||
| Dividend Growth | % | - | - | |||||
| Payout Ratio | % | -1.20% | -1.13% | |||||
| FCF/Debt | x | -0.02 | -0.57 | |||||
| Net Debt/EBITDA | x | -2.03 | -2.03 | |||||
| EBIT/Net interest | x | -0.56 | -0.56 | |||||
| Net debt/market cap | % | 1244.3% | 3631.3% | |||||
| Net debt/Equity | x | -1.85 | -1.80 | |||||
| Gross debt/equity | x | -1.97 | -1.89 | |||||
Company overview
Headquartered in Chengdu, People's Republic of China, Sichuan Languang Development Co., Ltd. primarily operates in the property development sector within China. Its business activities also encompass the modern service industry, biomedicine, and the cutting-edge area of 3D bioprinting. Founded in 1993, the company operated under the name Sichuan Di Kang Technology Pharmaceutical Co., Ltd. until April 2015, when it officially adopted its present designation.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Sichuan Languang Development Co., Ltd. (600466.SS)
Headquartered in Chengdu, People's Republic of China, Sichuan Languang Development Co., Ltd. primarily operates in the property development sector within China. Its business activities also encompass the modern service industry, biomedicine, and the cutting-edge area of 3D bioprinting. Founded in 1993, the company operated under the name Sichuan Di Kang Technology Pharmaceutical Co., Ltd. until April 2015, when it officially adopted its present designation.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free